Brian Coe

Brian Coe serves as Chief Executive Officer at Belay Diagnostics. Belay Diagnostics operates in the research sector with approximately 46.0 employees. The company is headquartered in Chicago, Illinois.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 3,772 executive contacts are available in Illinois.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 Hubspot YouTube Nginx Mobile Friendly Varnish Gravity Forms Vimeo WordPress.org Remote Circle Render Basis AI IoT Data Analytics

biotechnology research liquid biopsy cerebrospinal fluid dna testing brain cancer diagnosis spinal cord cancer testing molecular profiling genomic profiling biomarker detection tumor dna patient-centric diagnostics csf analysis neuro-oncology methylation analysis biopsy alternatives cancer genomics advanced diagnostics tumor heterogeneity high-performance assay clinical testing genomic insights csf tumor markers mgmt promoter methylation sensitive detection specificity in diagnostics patient safety surgical risks molecular assay non-invasive testing cns malignancies tdna sequencing clinical decision support test ordering genomic tests biological samples clinical research biotechnology advancements patient outcomes diagnostics technology csf sample collection bioinformatics cost-effective testing mutation analysis revolutionary diagnostics clinical trials tumor monitoring genetic variants oncology solutions molecular diagnostics information technology & services biotechnology health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Brian Coe in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Belay Diagnostics.

Brian Coe's Position in the MessageCEO Database

• •Brian Coe is 1 of 1 verified executive contact we track at Belay Diagnostics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,510 verified executive contacts in Illinois are in the database.
• •24 verified contacts work at research companies in the 46.0 employee range (same size as Belay Diagnostics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Brian Coe directly?

Brian Coe's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Belay Diagnostics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Brian Coe work for?

Brian Coe is Chief Executive Officer at Belay Diagnostics, a company in the research sector with 46.0 employees. The company is based in Chicago, Illinois.

Can I pitch or sell to Brian Coe?

As Chief Executive Officer at Belay Diagnostics, Brian Coe is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Brian Coe directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Brian Coe in?

Brian Coe works in the research industry as Chief Executive Officer at Belay Diagnostics. MessageCEO provides verified contact information for executives across all major industries.

Is Brian Coe's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Brian Coe's profile is kept up-to-date with the latest available information.

Last updated: July 24, 2026